Search results for Mavrilimumab
Mavrilimumab, Abbexa, abx831195
Mavrilimumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CSF2RA/CD116, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Mavrilimumab Biosimilar - Research Grade, ichor.bio, ICH5054
Detects human GM-CSF. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Mavrilimumab.
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Research Grade Mavrilimumab (HB112016), abinScience, HB112016
Host
Human
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Conjugation
Please provide the required information below so that we can quickly source your products.